COYA Coya Therapeutics Inc: Sof marja

Coya Therapeutics Inc (COYA) - korporativ logo

Coya Therapeutics, Inc. (COYA) neyroinflammasiyani bostirishga e'tibor qaratgan holda, Altsgeymer kasalligi va ALS ga qarshi kurashish uchun Treg terapiyasini ishlab chiqmoqda. Kompaniya hozirda o'z tadqiqotlarini moliyalashtirish uchun investitsiya kapitaliga tayanadi. Integral sof marja ko'rsatkichi tashqi moliyalashtirishga bo'lgan ushbu bog'liqlikni aks ettiradi va ushbu raqam -643.40 ni tashkil etdi. Inqilobiy multimodal dori vositalarining ishga tushirilishi aktivning moliyaviy profilini sezilarli darajada o'zgartirishi kutilmoqda.

Coya Therapeutics Inc (COYA) - Sof marja 28.04.2023dan 20.11.2026gacha

coyatherapeutics.com - tahliliy kesimlar va asosiy koʻrsatkichlar (COYA)

- aksiya kursi va ekspertlarning narx prognozi:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
Kompaniyaning barcha koʻrsatkichlari tahlili:coyatherapeutics.com - COYA
Coya Therapeutics, Inc. tayyor mahsulotlari

ALS ga qarshi innovatsion T-hujayra terapiyasini ishlab chiqayotgan Coya Therapeutics, Inc. (COYA) uchun ushbu ko'rsatkich daromadni sof foydaga aylantirish samaradorligining o'lchovi bo'lib xizmat qiladi. Daromad marjasi orqali aks etgan yakuniy foydaning umumiy savdoga nisbati biznesning operatsion xarajatlarni qoplash qobiliyatini namoyish etadi. Ushbu grafikdagi tendentsiya inflyatsiyaviy bosim ostidagi rentabellikning pasayish sur'atini vizuallashtiradi. Tahlil kapitalga intensiv rivojlanishlarning tashqi zarbalarga chidamliligini baholash imkonini beradi, bu esa faol o'sish bosqichida investitsiyalarni himoya qilish uchun juda muhimdir.

Asosiy raqobatchilar

BIIB: Sotuvning sof marjinal rentabelligi|Sof marja Neurocrine Biosciences Inc (NBIX)|RGC (Regencell Corp) - Sotuvning sof marjinal rentabelligi|AXSM: Sof foyda normasi|Sof marja acadia-pharm.com (ACAD)|Sotuvning sof marjinal rentabelligi Xenon Pharmaceuticals (XENE)|Sof marja Viking Therapeutics VKTX|Sof foyda normasi SUPN|CPRX - Sof marja|Sof marja Denali Therapeutics|HRMY: Sotuvning sof marjinal rentabelligi|Biohaven - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi AMLX|Trevi Therapeutics, Inc. (TRVI) - Kompaniya sotuv marjasi|Sof foyda bo'yicha sotuv rentabelligi PRAX (Praxis Medicines)|Anavex Corp - Sotuvning sof rentabelligi|Sof marja CeriBell CBLL|Kompaniya sotuv marjasi Prothena Biosciences (PRTA)|ALEC: Sof foyda bo'yicha sotuv rentabelligi|ANNX - Sotuvning sof marjinal rentabelligi|Omeros Corp. (OMER) - Sof marja|Sof marja Neurogene Inc. (NGNE)|Sof foyda bo'yicha sotuv rentabelligi ACIU|Sof marja VYGR|Sof marja Neumora (NMRA)|SCLX - Sof marja|Sotuvning sof marjinal rentabelligi TVGN (Tevogen Bio Holdings Inc.)|Sof foyda normasi ACOG|Cognition Therapeutics Inc. - Sotuvning sof marjinal rentabelligi|IKT - Sotuvning sof marjinal rentabelligi|SAVA: Sotuvning sof marjinal rentabelligi|Assertio Holdings, Inc. - Sof foyda normasi|Sof marja Vistagen|Sotuvning sof rentabelligi OVID (ovidrx.com)|Sof marja Acumen Pharmaceuticals, Inc. (ABOS)|CRVO - Sof marja|Alterity Therapeutics Ltd. - Sof foyda bo'yicha sotuv rentabelligi|CLNN - Sof foyda bo'yicha sotuv rentabelligi|PEPG - Sof marja|Kompaniya sotuv marjasi jupiterneurosciences.com JUNS|Relmada Therapeutics (RLMD) - Sof marja|ANVS (Annovis Bio, Inc.) - Sof marja|Sof marja gracetx.com|Sotuvning sof marjinal rentabelligi Firefly Neuroscience, Inc.|Sof marja ANEW Medical (KLTO)|NRSN - Sof marja|Sotuvning sof marjinal rentabelligi RVPH (Reviva Pharmaceuticals Holdings Inc.)|Kompaniyaning sof rentabelligi MTVA (metaviatx.com)|NeurAxis Inc. - Sotuvning sof marjinal rentabelligi|Kompaniya sotuv marjasi heliusmedical.com HSDT|PASG: Sotuvning sof marjinal rentabelligi|Neuphoria - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi NERV|ATHA: Sof foyda normasi|Sof marja Addex Therapeutics Ltd (ADXN)|ALZN (Alzamend Neuro Inc.) - Sof foyda normasi|Sotuvning sof marjinal rentabelligi CYCN (cyclerion.com)|Sof foyda bo'yicha marjinallik Protagenic|KTTA: Sof foyda bo'yicha sotuv rentabelligi|Sof foyda normasi CRGT (cortigent.com)|ATXI: Sotuvning sof marjinal rentabelligi|BCLI (BrainStorm Cell Therapeutics) - Sof marja|CARA (Cara Therapeutics Inc.) - Sotuvning sof marjinal rentabelligi|Sof marja CHRO|Sof foyda bo'yicha sotuv rentabelligi ELYM (Eliem Therapeutics)|Sof marja ITCI (Intra-Cellular Therapies Inc.)|Sotuvning sof marjinal rentabelligi LBPH (Longboard Pharma)|Sotuvning sof marjinal rentabelligi Marinus Pharmaceuticals Inc MRNS|NKGen Biotech Corp - Sotuvning sof marjinal rentabelligi|Sof foyda normasi NRBO (NeuroBo Pharma)|SAGE (Sage Therapeutics, Inc) - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof rentabelligi SNPX|Sof foyda bo'yicha sotuv rentabelligi TRVN|Sof marja VIGL|Sotuvning sof marjinal rentabelligi WENA|Kompaniya sotuv marjasi Cerevel